VYNE Therapeutics Inc.
VYNE | NASDAQ
$28.56
$0.00 (0.00%)
At close: Jul 27, 2026, 04:00 PM ET
Market Data
Market Cap $19.07M
Enterprise Value $19.04M
Beta 2.01
Average Volume 25.24K
Shares Outstanding (Diluted) 42.77K
Shares Change YoY -95%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US92941V3087
Price Performance
Price Change 1M N/A
Price Change 3M -10.4%
Price Change 6M -8.6%
Price Change YTD -1.5%
Price Change 1Y 32.8%
Price Change 3Y -79.2%
Price Change 5Y -97.4%
1M CAGR (ann.) -13.3%
1Y CAGR (ann.) -57.0%
5Y CAGR (ann.) -59.0%
All-Time CAGR -61.8%
Valuation
PE Ratio -0.04
Forward PE N/A
PEG Ratio 0.00
Forward PEG -0.00
PS Ratio 19.97
Forward PS 1.90
PB Ratio 686.82
P/FCF Ratio -1.13
P/Adj. FCF Ratio -1.01
P/OCF Ratio -0.07
EV/Sales 19.94
EV/EBIT -0.42
EV/EBITDA -0.42
EV/FCF -1.12
Earnings Yield -2230.3%
FCF Yield -88.8%
Adj. FCF Yield -98.9%
Financial Health
Net Cash $29.01K
Total Debt $0
Cash & Short-Term Investments $29.01K
Total Assets $30.16K
Current Ratio 12.53
Quick Ratio 12.53
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -227.16
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 99.4%
Operating Profit Margin -4877.1%
EBITDA Margin -4784.6%
Net Profit Margin -4417.3%
FCF Margin -1773.1%
Adj. FCF Margin -1974.8%
SBC / Revenue 201.7%
SBC Impact (per share) -11.4%
Returns
Return on Assets -139870.7%
Return on Equity -199.7%
Return on Invested Capital -159961.5%
Return on Capital Employed -167750.8%
Return on Tangible Assets -139870.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 32.9%
Revenue CAGR 5Y -34.8%
Revenue CAGR 10Y -15.1%
EPS CAGR 3Y -94.0%
EPS CAGR 5Y 11.2%
EPS CAGR 10Y 23.2%
FCF CAGR 3Y 17.6%
FCF CAGR 5Y 13.6%
FCF CAGR 10Y 0.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 2
EPS Growth Next 3Y 28.1%
Revenue Growth Next 3Y 274.1%
Earnings Date Aug 13, 2026
EPS Estimate (next Q) -$0.18
EPS Growth Est (next Q) -97.2%
Revenue Est (next Q) $200K
Revenue Growth Est (next Q) 189.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $5.75
Price Target Upside -79.9%
Cash Flow
Operating Cash Flow $-16.93M
Free Cash Flow $-16.93M
Adj. Free Cash Flow $-18.86M
FCF Per Share -$395.93
OCF Per Share -$395.93
OCF/S Ratio -1773.1%
Income Statement
Revenue $955K
Gross Profit $949K
Operating Income $-46.58M
EBITDA $-45.7M
Net Income $-42.19M
EPS (Diluted) -$636.98
Revenue / Employee $95.5K
Profit / Employee $-4.22M
Employees 10
Add to Watchlist
Select watchlists to add or remove VYNE